YBX1 and metabolic dysfunction-associated steatotic liver disease: To investigate whether YBX1 is involved in MASLD, we first analyzed the gene expression profile of patients with MASLD through GEO datasets (GSE193084, GSE15653, and GSE135251) and found that YBX1 is among the higher expressed candidates (Figure 1A).